Evidence map›Paper›PMID 20417090›Full record

ReviewCurrent opinion in genetics & development2010

Candidate gene association studies: successes and failures.

Boris Pasche, Nengjun Yi

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in genetics & development, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. TGF-β signaling pathway and breast cancer susceptibility.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2011
    Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Boris PascheDivision of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham and UAB Comprehensive Cancer Center, Birmingham, AL 35294-3300, USA. Boris.Pasche@ccc.uab.edu
Nengjun Yi
University of Alabama at Birmingham · US

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Study of Lupus Vascular and Bone Longterm EndpointsP60AR048098 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI RAMSEY-GOLDMAN, ROSALIND · 2002 to 2011
$11.4M
Bayesian Methods for Mapping Complex Epistatic GenesR01GM069430 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YI, NENGJUN · 2005 to 2013
$2.3M
TGF-beta polymorphisms and breast cancer in familiesR01CA112520 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PASCHE, BORIS · 2005 to 2013
$2.1M
TGFBR1 Signaling in Colorectal CancerR01CA137000 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PASCHE, BORIS · 2010 to 2014
$1.5M
TGF-beta pathway polymorphisms and colon cancer riskR01CA108741 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PASCHE, BORIS · 2006 to 2008
$804k
NCI NIH HHS CA108741NCI NIH HHS CA112520NCI NIH HHS CA137000NCI NIH HHS P30 CA012197NCI NIH HHS R01 CA108741NCI NIH HHS R01 CA112520NCI NIH HHS R01 CA137000NIAMS NIH HHS 5P60AR048098NIAMS NIH HHS P60 AR048098NIGMS NIH HHS GM069430NIGMS NIH HHS R01 GM069430
6 · The paper itself

Abstract

Epidemiologic studies of twins indicate that 20-40% of common tumors such as breast, colorectal, and prostate cancers are inherited. However, the effect of high penetrance tumor susceptibility genes such as APC, BRCA1, BRAC2, MSH1, MLH2 and MSH6 only accounts for a small fraction of these cancers. Low to moderate penetrance tumor susceptibility genes likely account for the large remaining proportion of familial cancer risk. Candidate tumor susceptibility genes have been identified based on the discovery of tumor-specific mutations, in vitro experiments, as well as animal models of cancer. Translational studies based on in vitro and in vivo discoveries have led to the identification of novel phenotypes and genotypes associated with cancer in humans. Case-control studies followed by validation studies and meta-analyses have unveiled several novel tumor susceptibility genes, several of which belong to genes encoding metabolizing enzymes and genes from the TGF-beta signaling pathway. Together with genome-wide association studies, candidate gene approaches are likely to fill a large gap in our knowledge of the genetic basis of cancer within the next decade.

Indexed as

Polymorphism, Single NucleotideAnimalsDisease Models, AnimalGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansNeoplasmsPhenotypeProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type I

Identifiers

PMID20417090
PMCPMC2885524
OpenAlexW2065360071

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.